Drugs / V-5 Immunitor
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01222338 Comparator | Jan → Dec 2010 | tuberculosis | Lisichansk Regional Tuberculosis Dispensary | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V-5 Immunitor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01222338 ↗ |
| Known as | V5, V-5 immunitor | “V5, V-5 immunitor” NCT01222338 ↗ |
| Route | Oral | “received a once-daily V-5 Immunitor (V5) immunotherapy pill” PMID 21182457 ↗ Dec 2010 |